Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China

BACKGROUND: Former single center studies indicated that HER2 assessment with two primary tumor blocks (dual block HER2 assessment) could be an efficient and practical approach to overcome the adverse impact of heterogeneity and acquire a HER2 positive rate in gastric cancer (GC). This multicenter pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Chen, Sun, Miaomiao, Jin, Mei, Li, Zengshan, Qin, Rong, Ren, Guoping, Sun, Wenyong, Chen, Lirong, Luan, Lijuan, Liu, Yalan, Jiang, Dongxian, Chen, Lingli, Luo, Rongkui, Hou, Yingyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238183/
https://www.ncbi.nlm.nih.gov/pubmed/35765007
http://dx.doi.org/10.1186/s13000-022-01230-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238183/
https://www.ncbi.nlm.nih.gov/pubmed/35765007
http://dx.doi.org/10.1186/s13000-022-01230-7

Ejemplares similares